Boji Medical Technology Co.,Ltd. (SHE:300404)
15.17
+0.31 (2.09%)
At close: Sep 23, 2026
Boji Medical Technology Revenue
Boji Medical Technology had revenue of 233.98M CNY in the quarter ending June 30, 2026, with 5.12% growth. This brings the company's revenue in the last twelve months to 961.34M, up 26.15% year-over-year. In the year 2025, Boji Medical Technology had annual revenue of 868.64M with 17.06% growth.
Revenue (ttm)
961.34M
Revenue Growth
+26.15%
P/S Ratio
6.05
Revenue / Employee
802.45K
Employees
1,198
Market Cap
5.81B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 868.64M | 126.62M | 17.06% |
| Dec 31, 2024 | 742.02M | 186.19M | 33.50% |
| Dec 31, 2023 | 555.83M | 132.15M | 31.19% |
| Jan 1, 2023 | 423.68M | 99.48M | 30.68% |
| Jan 1, 2022 | 324.20M | 63.73M | 24.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 15.93B |
| Youcare Pharmaceutical Group | 2.46B |
| Kexing Biopharm | 1.44B |
| Shenzhen Weiguang Biological Products | 1.20B |
| ChemPartner PharmaTech | 1.16B |
| R&G PharmaStudies | 939.31M |
| Wuhan Keqian Biology Co.,Ltd | 836.28M |
| Zhejiang Ausun Pharmaceutical | 778.50M |